The Emicizumab assay is now performed in special coagulation at QEHB. Samples are no longer referred to Birmingham Children's Hospital.
Emicizumab (or Hemlibra) is a monoclonal antibody that mimics the function of factor VIII by bridging activated factor IX and factor X to restore the function of missing activated factor VIII, which is needed for haemostasis.
ADAMTS13 Activity, HIT Screens and Collagen Binding (vW:CBA) Assays are now performed by automated chemiluminescent immunoassay on the Acustar analsyer.
Please see individual test information for updated reference ranges.
The Haematology and Transfusion departments at UHB have now transitioned from 8217 and 8784 to one UKAS number 8784 covering all UHB Haematology sites including Queen Elizabeth Hospital, Birmingham Heartlands Hospital, Good Hope Hospital and Solihull Hospital.
Queen Elizabeth pathology services are are based at Queen Elizabeth Hospital - University Hospitals Birmingham - Edgbaston. The laboratories are part of a wider laboratory grouping for University Hospitals Birmingham, which includes laboratories from Heartlands Hospital, Good Hope Hospital and Solihull Hospital (HGS Laboratories). All laboratories are ISO 15189 accreditated for their listed repertoire, unless otherwise noted. Site specific information can be accessed below.